United States Recombinant Protein Market Report 2016

Publisher Name :
Date: 07-Oct-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Recombinant Protein

Revenue, means the sales value of Recombinant Protein

This report studies sales (consumption) of Recombinant Protein in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer HealthCare Pharmaceuticals, Inc. (US)

- GlaxoSmithKline (UK)

- AbbVie, Inc. (US)

- Anavex Life Sciences Corp. (US)

- Baxter International, Inc. (US)

- Biocon (India)

- Eli Lilly (US)

- F. Hoffmann-La Roche Ltd. (Switzerland)

- Genentech (US)

- Janssen Biotech, Inc. (US)

- Kemwell Biopharma (India)

- Novartis (Switzerland)

- Sun Pharmaceutical Industries Ltd. (India)

- Sanofi S.A. (France)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Protein in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Recombinant Protein Market Report 2016

Table of Contents
United States Recombinant Protein Market Report 2016
1 Recombinant Protein Overview
1.1 Product Overview and Scope of Recombinant Protein
1.2 Classification of Recombinant Protein
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Recombinant Protein
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Recombinant Protein (2011-2021)
1.4.1 United States Recombinant Protein Sales and Growth Rate (2011-2021)
1.4.2 United States Recombinant Protein Revenue and Growth Rate (2011-2021)
2 United States Recombinant Protein Competition by Manufacturers
2.1 United States Recombinant Protein Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Recombinant Protein Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Recombinant Protein Average Price by Manufactures (2015 and 2016)
2.4 Recombinant Protein Market Competitive Situation and Trends
2.4.1 Recombinant Protein Market Concentration Rate
2.4.2 Recombinant Protein Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Recombinant Protein Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Recombinant Protein Sales and Market Share by Type (2011-2016)
3.2 United States Recombinant Protein Revenue and Market Share by Type (2011-2016)
3.3 United States Recombinant Protein Price by Type (2011-2016)
3.4 United States Recombinant Protein Sales Growth Rate by Type (2011-2016)
4 United States Recombinant Protein Sales (Volume) by Application (2011-2016)
4.1 United States Recombinant Protein Sales and Market Share by Application (2011-2016)
4.2 United States Recombinant Protein Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Recombinant Protein Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Recombinant Protein Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer HealthCare Pharmaceuticals, Inc. (US)
5.2.2 Recombinant Protein Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline (UK)
5.3.2 Recombinant Protein Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline (UK) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 AbbVie, Inc. (US)
5.4.2 Recombinant Protein Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 AbbVie, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Anavex Life Sciences Corp. (US)
5.5.2 Recombinant Protein Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Anavex Life Sciences Corp. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Baxter International, Inc. (US)
5.6.2 Recombinant Protein Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Baxter International, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Biocon (India)
5.7.2 Recombinant Protein Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Biocon (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Eli Lilly (US)
5.8.2 Recombinant Protein Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Eli Lilly (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 F. Hoffmann-La Roche Ltd. (Switzerland)
5.9.2 Recombinant Protein Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Genentech (US)
5.10.2 Recombinant Protein Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Genentech (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Janssen Biotech, Inc. (US)
5.12 Kemwell Biopharma (India)
5.13 Novartis (Switzerland)
5.14 Sun Pharmaceutical Industries Ltd. (India)
5.15 Sanofi S.A. (France)
6 Recombinant Protein Manufacturing Cost Analysis
6.1 Recombinant Protein Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Recombinant Protein
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Recombinant Protein Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Recombinant Protein Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Recombinant Protein Market Forecast (2016-2021)
10.1 United States Recombinant Protein Sales, Revenue Forecast (2016-2021)
10.2 United States Recombinant Protein Sales Forecast by Type (2016-2021)
10.3 United States Recombinant Protein Sales Forecast by Application (2016-2021)
10.4 Recombinant Protein Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Recombinant Protein
Table Classification of Recombinant Protein
Figure United States Sales Market Share of Recombinant Protein by Type in 2015
Table Application of Recombinant Protein
Figure United States Sales Market Share of Recombinant Protein by Application in 2015
Figure United States Recombinant Protein Sales and Growth Rate (2011-2021)
Figure United States Recombinant Protein Revenue and Growth Rate (2011-2021)
Table United States Recombinant Protein Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Protein Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Protein Sales Share by Manufacturers
Figure 2016 Recombinant Protein Sales Share by Manufacturers
Table United States Recombinant Protein Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Protein Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Protein Revenue Share by Manufacturers
Table 2016 United States Recombinant Protein Revenue Share by Manufacturers
Table United States Market Recombinant Protein Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Protein Average Price of Key Manufacturers in 2015
Figure Recombinant Protein Market Share of Top 3 Manufacturers
Figure Recombinant Protein Market Share of Top 5 Manufacturers
Table United States Recombinant Protein Sales by Type (2011-2016)
Table United States Recombinant Protein Sales Share by Type (2011-2016)
Figure United States Recombinant Protein Sales Market Share by Type in 2015
Table United States Recombinant Protein Revenue and Market Share by Type (2011-2016)
Table United States Recombinant Protein Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Recombinant Protein by Type (2011-2016)
Table United States Recombinant Protein Price by Type (2011-2016)
Figure United States Recombinant Protein Sales Growth Rate by Type (2011-2016)
Table United States Recombinant Protein Sales by Application (2011-2016)
Table United States Recombinant Protein Sales Market Share by Application (2011-2016)
Figure United States Recombinant Protein Sales Market Share by Application in 2015
Table United States Recombinant Protein Sales Growth Rate by Application (2011-2016)
Figure United States Recombinant Protein Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Basic Information List
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table GlaxoSmithKline (UK) Basic Information List
Table GlaxoSmithKline (UK) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline (UK) Recombinant Protein Sales Market Share (2011-2016)
Table AbbVie, Inc. (US) Basic Information List
Table AbbVie, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Anavex Life Sciences Corp. (US) Basic Information List
Table Anavex Life Sciences Corp. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Anavex Life Sciences Corp. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Baxter International, Inc. (US) Basic Information List
Table Baxter International, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxter International, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Biocon (India) Basic Information List
Table Biocon (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon (India) Recombinant Protein Sales Market Share (2011-2016)
Table Eli Lilly (US) Basic Information List
Table Eli Lilly (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly (US) Recombinant Protein Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales Market Share (2011-2016)
Table Genentech (US) Basic Information List
Table Genentech (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech (US) Recombinant Protein Sales Market Share (2011-2016)
Table Janssen Biotech, Inc. (US) Basic Information List
Table Janssen Biotech, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Biotech, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)
Table Kemwell Biopharma (India) Basic Information List
Table Kemwell Biopharma (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kemwell Biopharma (India) Recombinant Protein Sales Market Share (2011-2016)
Table Novartis (Switzerland) Basic Information List
Table Novartis (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis (Switzerland) Recombinant Protein Sales Market Share (2011-2016)
Table Sun Pharmaceutical Industries Ltd. (India) Basic Information List
Table Sun Pharmaceutical Industries Ltd. (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Industries Ltd. (India) Recombinant Protein Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Recombinant Protein Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein
Figure Manufacturing Process Analysis of Recombinant Protein
Figure Recombinant Protein Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Major Manufacturers in 2015
Table Major Buyers of Recombinant Protein
Table Distributors/Traders List
Figure United States Recombinant Protein Production and Growth Rate Forecast (2016-2021)
Figure United States Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)
Table United States Recombinant Protein Production Forecast by Type (2016-2021)
Table United States Recombinant Protein Consumption Forecast by Application (2016-2021)
  • Global Animal Plasma and Derivatives Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 105
    In this report, the global Animal Plasma and Derivatives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Animal Plasma and Derivatives in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Silver Dressings Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 115
    In this report, the global Silver Dressings market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Silver Dressings in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Global Acute Lung Injury Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 115
    In this report, the global Acute Lung Injury market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Acute Lung Injury in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China -......
  • Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Attention Deficit Hyperactivity Disorder (ADHD) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Attention Deficit Hyperactivity Disorder (ADHD) Drugs in these regions, from 2012 to 2022 (forecast),......
  • Global Hypereosinophilic Syndrome Drug Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Hypereosinophilic Syndrome Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hypereosinophilic Syndrome Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Eu......
  • Global Progressive Multifocal Leukoencephalopathy Drug Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Progressive Multifocal Leukoencephalopathy Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Progressive Multifocal Leukoencephalopathy Drug in these regions, from 2012 to 2022 (forecast), covering......
  • Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 116
    In this report, the global Hypoxia Inducible Factor 1 Alpha Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hypoxia Inducible Factor 1 Alpha Inhibitor in these regions, from 2012 to 2022 (forecast), covering - Nor......
  • Global Injectable Fillers Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 107
    In this report, the global Injectable Fillers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Injectable Fillers in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China ......
  • Global Venous Stents Market Research Report 2017
    Published: 23-Nov-2017        Price: US 2900 Onwards        Pages: 107
    In this report, the global Venous Stents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Venous Stents in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs